Literature DB >> 2183625

Mechanisms of tumor necrosis factor-alpha alteration of PMN adhesion and migration.

J L Salyer1, J F Bohnsack, W A Knape, A O Shigeoka, E R Ashwood, H R Hill.   

Abstract

We have investigated the effects of recombinant human tumor necrosis factor-alpha (rhTNF alpha) on polymorphonuclear leukocytes (PMNs), concentrating on the mechanisms involved in the alterations of PMN-directed migration and adherence by this cytokine. RhTNF alpha profoundly suppressed PMN chemotaxis toward FMLP by 80%. At similar concentrations, it enhanced adhesion to gelatin-coated plastic dishes by more than tenfold and increased the expression of the CD11b antigen to 182% of the control. The monoclonal antibody 60.1, which is directed against the alpha chain of the CD11b/CD18 complex, completely blocked rhTNF alpha, induced inhibition of the chemotactic response to FMLP, and rhTNF alpha induced hyperadherence, suggesting that these effects were related to rhTNF alpha's effects on CD11b antigen expression. The fluid state of the PMN membrane was also decreased by rhTNF alpha. N-butanol, a known membrane fluidizer, partially inhibited the effect of rhTNF alpha on membrane fluidity and chemotaxis and completely reversed its effects on adherence and the expression of the CD11b antigen. Pentoxifylline, an agent that has previously been studied for its ability to prevent some effects of rhTNF alpha on PMNs, completely prevented the effect of rhTNF alpha on chemotaxis, the expression of the CD11b antigen, and membrane fluidity. Pentoxifylline partially prevented changes in adherence caused by this cytokine. Increased CD11b antigen expression caused by rhTNF alpha may result in enhanced PMN adhesion and suppression of migration. These events may, in turn, lead to the accumulation of PMNs on the vascular endothelium, resulting in the extensive vascular and tissue damage that is seen in gram-negative sepsis.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2183625      PMCID: PMC1877646     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  30 in total

1.  An endotoxin-induced serum factor that causes necrosis of tumors.

Authors:  E A Carswell; L J Old; R L Kassel; S Green; N Fiore; B Williamson
Journal:  Proc Natl Acad Sci U S A       Date:  1975-09       Impact factor: 11.205

2.  Chemoattractant receptor functions in human polymorphonuclear leukocytes are divergently altered by membrane fluidizers.

Authors:  I Yuli; A Tomonaga; R Synderman
Journal:  Proc Natl Acad Sci U S A       Date:  1982-10       Impact factor: 11.205

3.  Subcellular localization of the large subunit of Mo1 (Mo1 alpha; formerly gp 110), a surface glycoprotein associated with neutrophil adhesion.

Authors:  R F Todd; M A Arnaout; R E Rosin; C A Crowley; W A Peters; B M Babior
Journal:  J Clin Invest       Date:  1984-10       Impact factor: 14.808

4.  Abnormalities of polymorphonuclear leukocyte function associated with a heritable deficiency of high molecular weight surface glycoproteins (GP138): common relationship to diminished cell adherence.

Authors:  D C Anderson; F C Schmalstieg; M A Arnaout; S Kohl; M F Tosi; N Dana; G J Buffone; B J Hughes; B R Brinkley; W D Dickey
Journal:  J Clin Invest       Date:  1984-08       Impact factor: 14.808

5.  Evidence for distinct intracellular pools of receptors for C3b and C3bi in human neutrophils.

Authors:  J J O'Shea; E J Brown; B E Seligmann; J A Metcalf; M M Frank; J I Gallin
Journal:  J Immunol       Date:  1985-04       Impact factor: 5.422

6.  Activation of human polymorphonuclear neutrophil functions by interferon-gamma and tumor necrosis factors.

Authors:  M R Shalaby; B B Aggarwal; E Rinderknecht; L P Svedersky; B S Finkle; M A Palladino
Journal:  J Immunol       Date:  1985-09       Impact factor: 5.422

7.  Purification and partial amino acid sequence of rabbit tumor necrosis factor.

Authors:  K Haranaka; N Satomi; A Sakurai; H Nariuchi
Journal:  Int J Cancer       Date:  1985-09-15       Impact factor: 7.396

8.  Anti-Mac-1 selectively inhibits the mouse and human type three complement receptor.

Authors:  D I Beller; T A Springer; R D Schreiber
Journal:  J Exp Med       Date:  1982-10-01       Impact factor: 14.307

9.  Studies of endotoxin-induced decrease in lipoprotein lipase activity.

Authors:  M Kawakami; A Cerami
Journal:  J Exp Med       Date:  1981-09-01       Impact factor: 14.307

10.  Purification of cachectin, a lipoprotein lipase-suppressing hormone secreted by endotoxin-induced RAW 264.7 cells.

Authors:  B Beutler; J Mahoney; N Le Trang; P Pekala; A Cerami
Journal:  J Exp Med       Date:  1985-05-01       Impact factor: 14.307

View more
  13 in total

1.  The intratracheal administration of endotoxin and cytokines. I. Characterization of LPS-induced IL-1 and TNF mRNA expression and the LPS-, IL-1-, and TNF-induced inflammatory infiltrate.

Authors:  T R Ulich; L R Watson; S M Yin; K Z Guo; P Wang; H Thang; J del Castillo
Journal:  Am J Pathol       Date:  1991-06       Impact factor: 4.307

2.  Selective up-regulation of human granulocyte integrins and complement receptor 1 by cytokines.

Authors:  G A Limb; A S Hamblin; R A Wolstencroft; D C Dumonde
Journal:  Immunology       Date:  1991-12       Impact factor: 7.397

3.  Drug modulation of antigen-induced paw oedema in guinea-pigs: effects of lipopolysaccharide, tumour necrosis factor and leucocyte depletion.

Authors:  J I da Motta; F Q Cunha; B B Vargaftig; S H Ferreira
Journal:  Br J Pharmacol       Date:  1994-05       Impact factor: 8.739

4.  Increased CD11/CD18 expression on peripheral blood leucocytes of patients with sarcoidosis.

Authors:  Z Shakoor; A S Hamblin
Journal:  Clin Exp Immunol       Date:  1992-10       Impact factor: 4.330

5.  Priming of human neutrophil functions by tumor necrosis factor: enhancement of superoxide anion generation, degranulation, and chemotaxis to chemoattractants C5a and F-Met-Leu-Phe.

Authors:  M S Bajaj; R R Kew; R O Webster; T M Hyers
Journal:  Inflammation       Date:  1992-06       Impact factor: 4.092

6.  Therapeutic potentials of pentoxifylline for treatment of cardiovascular diseases.

Authors:  Ming Zhang; Yan-Jun Xu; Shushma A Mengi; Amarjit S Arneja; Naranjan S Dhalla
Journal:  Exp Clin Cardiol       Date:  2004

7.  Adenosine inhibits platelet-activating factor, but not tumour necrosis factor-alpha-induced priming of human neutrophils.

Authors:  A G Stewart; T Harris
Journal:  Immunology       Date:  1993-01       Impact factor: 7.397

8.  Leukocyte activation by isolated hyperthermic liver and limb perfusion due to malignancy.

Authors:  J P Arnestad; A Bengtsson; J P Bengtson; L Hafström; H Redl; G Schlag
Journal:  World J Surg       Date:  1995 Nov-Dec       Impact factor: 3.352

9.  In vitro effects of oxidized low density lipoprotein on CD11b/CD18 and L-selectin presentation on neutrophils and monocytes with relevance for the in vivo situation.

Authors:  H A Lehr; F Krombach; S Münzing; R Bodlaj; S I Glaubitt; D Seiffge; C Hübner; U H von Andrian; K Messmer
Journal:  Am J Pathol       Date:  1995-01       Impact factor: 4.307

10.  Neutrophil Inhibitory Factor Selectively Inhibits the Endothelium-Driven Transmigration of Eosinophils In Vitro and Airway Eosinophilia in OVA-Induced Allergic Lung Inflammation.

Authors:  Silvia Schnyder-Candrian; Isabelle Maillet; Marc Le Bert; Lea Brault; Muazzam Jacobs; Bernhard Ryffel; Bruno Schnyder; René Moser
Journal:  J Allergy (Cairo)       Date:  2012-12-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.